Researchers are exploring the synthesis of metal nanoparticles, specifically curcumin-capped copper nanoparticles (CU-NPs), to enhance cancer treatment and drug delivery.
The study evaluated CU-NPs for their effects on angiogenesis, cell proliferation, and migration in the MDA-MB-231 breast cancer cell line, using assays like the chorioallantoic membrane (CAM) model and the MTT cytotoxicity assay.
Results indicated that CU-NPs did not show significant antiangiogenic or anticancer activity compared to native curcumin, and the study discusses potential reasons based on nanoparticle synthesis methods.